Maximus, Inc. (NYSE:MMS) Holdings Decreased by Verus Financial Partners Inc.

Verus Financial Partners Inc. cut its holdings in Maximus, Inc. (NYSE:MMS) by 31.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 3,442 shares of the health services provider’s stock after selling 1,607 shares during the period. Verus Financial Partners Inc.’s holdings in Maximus were worth $264,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Washington Capital Management Inc. grew its holdings in shares of Maximus by 67.3% during the fourth quarter. Washington Capital Management Inc. now owns 9,200 shares of the health services provider’s stock valued at $687,000 after purchasing an additional 3,700 shares during the last quarter. Robeco Institutional Asset Management B.V. boosted its position in Maximus by 45.3% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 25,615 shares of the health services provider’s stock valued at $1,912,000 after purchasing an additional 7,980 shares during the period. R Squared Ltd bought a new position in Maximus during the 4th quarter worth $54,000. KBC Group NV increased its position in Maximus by 78.1% in the fourth quarter. KBC Group NV now owns 2,905 shares of the health services provider’s stock worth $217,000 after buying an additional 1,274 shares during the period. Finally, Blue Trust Inc. increased its position in Maximus by 27.2% in the fourth quarter. Blue Trust Inc. now owns 1,666 shares of the health services provider’s stock worth $124,000 after buying an additional 356 shares during the period. Institutional investors own 97.21% of the company’s stock.

Wall Street Analyst Weigh In

MMS has been the subject of several recent research reports. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target for the company in a research report on Thursday, January 2nd. StockNews.com raised shares of Maximus from a “hold” rating to a “buy” rating in a research note on Wednesday.

Maximus Stock Down 0.9 %

MMS stock opened at $75.31 on Friday. The firm’s 50-day moving average is $74.71 and its two-hundred day moving average is $83.99. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $4.30 billion, a price-to-earnings ratio of 15.06 and a beta of 0.73. Maximus, Inc. has a 52 week low of $69.72 and a 52 week high of $93.97.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Saturday, February 15th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.59%. The ex-dividend date is Friday, February 14th. Maximus’s dividend payout ratio (DPR) is presently 24.00%.

Insider Transactions at Maximus

In other Maximus news, Director Raymond B. Ruddy bought 3,490 shares of Maximus stock in a transaction that occurred on Thursday, December 12th. The stock was purchased at an average cost of $71.46 per share, for a total transaction of $249,395.40. Following the completion of the acquisition, the director now owns 112,520 shares of the company’s stock, valued at approximately $8,040,679.20. This represents a 3.20 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Bruce Caswell purchased 3,500 shares of the company’s stock in a transaction on Tuesday, December 17th. The stock was bought at an average cost of $70.64 per share, for a total transaction of $247,240.00. Following the acquisition, the chief executive officer now directly owns 275,929 shares of the company’s stock, valued at $19,491,624.56. This represents a 1.28 % increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 7,063 shares of company stock valued at $502,017. Corporate insiders own 1.60% of the company’s stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.